Marchex (MCHX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Nov, 2025Executive summary
Completed a two-year transformation into an AI-powered SaaS analytics provider, centralizing technology and data on the OneStack cloud platform and expanding product offerings for conversational intelligence.
Launched new AI-driven products, unified customer interface, and entered strategic partnerships, including with Microsoft, to broaden market reach and sales opportunities.
Announced a new share repurchase program authorizing up to 3 million Class B shares with no expiration date, replacing prior programs.
Focused on actionable insights for enterprise clients in B2B2C verticals, aiming to drive operational excellence and revenue acceleration.
Management highlights ongoing investments in cloud infrastructure, product development, and sales and marketing, with a focus on strategic execution and customer experience optimization.
Financial highlights
Q1 2025 revenue was $11.4 million, down from $11.6 million in Q1 2024, impacted by lower call volumes, seasonal factors, and timing of new sales.
Net loss for Q1 2025 was $2.0 million ($0.05 per diluted share), compared to $1.5 million ($0.03 per share) in Q1 2024.
Gross margin increased by 8% year-over-year to 63%, driven by operational efficiencies from OneStack.
Operating expenditures decreased in some areas but overall operating expenses rose to $13.3 million from $12.9 million year-over-year.
Cash and cash equivalents totaled $10.0 million as of March 31, 2025, down from $12.8 million at year-end 2024.
Outlook and guidance
Targeting over $12.5 million in quarterly revenue and $1.5 million in quarterly adjusted EBITDA by end of 2025, with annualized revenue run rate expected to reach $50 million or more and adjusted EBITDA of $6 million or higher.
Management aims for $100 million annual revenue in coming years, leveraging new AI solutions and expanded channels.
Q2 2025 revenue expected to increase sequentially, with adjusted EBITDA projected to be positive.
Management believes current resources are sufficient to fund operations and strategic initiatives for at least the next twelve months, but macroeconomic factors could impact plans.
Additional equity or debt financing may be needed to support acquisitions or long-term obligations if required.
Latest events from Marchex
- AI-driven product launches and the Archenia deal set the stage for accelerated growth in 2026.MCHX
Q4 202525 Mar 2026 - Net loss narrowed and adjusted EBITDA improved as revenue is set to grow in Q3.MCHX
Q2 20242 Feb 2026 - Q3 2024 delivered $12.6M revenue, narrowed losses, and set the stage for AI-driven growth in 2025.MCHX
Q3 202417 Jan 2026 - 2025 is set for sequential growth and margin improvement, driven by new AI products and partnerships.MCHX
Q4 202424 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation practices.MCHX
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and performance-based compensation highlight strong governance.MCHX
Proxy Filing1 Dec 2025 - Annual proxy details director elections, voting proposals, and governance disclosures.MCHX
Proxy Filing1 Dec 2025 - Q2 2025 saw revenue dip 3% but net income and operational efficiency improved.MCHX
Q2 202523 Nov 2025 - Q3 revenue fell, but profitability improved and Archenia acquisition aims for accelerated AI growth.MCHX
Q3 202517 Nov 2025